CMPX vs SRPT · $367.4M cap vs rev $1.90B
Compass Therapeutics Inc. (CMPX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
CMPX does not have a complete income-statement cache yet.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
CMPX currently screens at market cap $367.4M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the CMPX and SRPT stock pages for the full models.
Not investment advice.